Biomarkers to Detect Endocrine Therapy Resistance
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Cancer|Breast Cancer|Lobular Breast Carcinoma
Interventions: DRUG: 18F-fluorofuranylnorprogesterone|DEVICE: Liquid Biopsy|DEVICE: Positron Emission Tomography/Computed Tomography
Sponsor: University of Wisconsin, Madison